JP2016534143A5 - - Google Patents

Download PDF

Info

Publication number
JP2016534143A5
JP2016534143A5 JP2016542643A JP2016542643A JP2016534143A5 JP 2016534143 A5 JP2016534143 A5 JP 2016534143A5 JP 2016542643 A JP2016542643 A JP 2016542643A JP 2016542643 A JP2016542643 A JP 2016542643A JP 2016534143 A5 JP2016534143 A5 JP 2016534143A5
Authority
JP
Japan
Prior art keywords
carbonyl
phthalazin
azetidine
fluoro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016534143A (ja
JP6180643B2 (ja
Filing date
Publication date
Priority claimed from KR1020140120152A external-priority patent/KR101670126B1/ko
Application filed filed Critical
Publication of JP2016534143A publication Critical patent/JP2016534143A/ja
Publication of JP2016534143A5 publication Critical patent/JP2016534143A5/ja
Application granted granted Critical
Publication of JP6180643B2 publication Critical patent/JP6180643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542643A 2013-09-13 2014-09-12 新規フタラジノン誘導体及びその製造方法「A novel phtalazinone derivatives and manufacturing process thereof」 Active JP6180643B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20130110170 2013-09-13
KR10-2013-0110170 2013-09-13
KR10-2014-0120152 2014-09-11
KR1020140120152A KR101670126B1 (ko) 2013-09-13 2014-09-11 신규 프탈라지논 유도체 및 그 제조방법
PCT/KR2014/008523 WO2015037939A1 (en) 2013-09-13 2014-09-12 A novel phtalazinone derivatives and manufacturing process thereof

Publications (3)

Publication Number Publication Date
JP2016534143A JP2016534143A (ja) 2016-11-04
JP2016534143A5 true JP2016534143A5 (enExample) 2017-06-15
JP6180643B2 JP6180643B2 (ja) 2017-08-16

Family

ID=53024930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542643A Active JP6180643B2 (ja) 2013-09-13 2014-09-12 新規フタラジノン誘導体及びその製造方法「A novel phtalazinone derivatives and manufacturing process thereof」

Country Status (25)

Country Link
US (3) USRE49338E1 (enExample)
EP (1) EP3030557B1 (enExample)
JP (1) JP6180643B2 (enExample)
KR (1) KR101670126B1 (enExample)
CN (1) CN105793248B (enExample)
AU (1) AU2014319132C1 (enExample)
BR (1) BR112016004979B1 (enExample)
CA (1) CA2923614C (enExample)
DK (1) DK3030557T3 (enExample)
ES (1) ES2953834T3 (enExample)
FI (1) FI3030557T3 (enExample)
HR (1) HRP20230998T1 (enExample)
HU (1) HUE062770T2 (enExample)
IL (1) IL244548B (enExample)
LT (1) LT3030557T (enExample)
MX (1) MX379467B (enExample)
MY (1) MY195343A (enExample)
PL (1) PL3030557T3 (enExample)
PT (1) PT3030557T (enExample)
RS (1) RS64477B1 (enExample)
RU (1) RU2636585C2 (enExample)
SG (1) SG11201600549TA (enExample)
SI (1) SI3030557T1 (enExample)
SM (1) SMT202300268T1 (enExample)
WO (1) WO2015037939A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101670126B1 (ko) * 2013-09-13 2016-10-27 일동제약(주) 신규 프탈라지논 유도체 및 그 제조방법
CA3129516A1 (en) * 2018-02-28 2019-09-06 The Trustees Of The University Of Pennsylvania Low affinity poly(ad-ribose) polymerase 1 dependent cytotoxic agents
KR102913343B1 (ko) * 2020-04-21 2026-01-15 아이디언스 주식회사 프탈라지논 화합물의 결정형
WO2021214502A1 (en) * 2020-04-21 2021-10-28 Idience Co., Ltd. Process for preparing a phthalazinone derivative and intermediates thereof
US20230159469A1 (en) * 2020-05-08 2023-05-25 Txinno Bioscience Inc. Novel phthalazine derivative having ectonucloeotide pyrophosphatase/phosphodieste rase inhibitory activity, and use thereof
US12059419B2 (en) * 2020-10-16 2024-08-13 Idience Co., Ltd. Pharmaceutical composition comprising phthalazinone derivatives
US20230391752A1 (en) * 2020-10-22 2023-12-07 Chulalongkorn University Pyrrolidine-3-carboxamide derivatives and related uses
KR102977180B1 (ko) * 2021-03-04 2026-06-15 아이디언스 주식회사 Parp 억제제에 내성을 가진 환자군의 암 치료제로서의 프탈라지논 유도체의 항암제 용도
WO2022186649A1 (ko) * 2021-03-04 2022-09-09 아이디언스 주식회사 Parp 억제제에 내성을 가진 환자군의 암 치료제로서의 프탈라지논 유도체의 항암제 용도
TW202313040A (zh) * 2021-06-02 2023-04-01 南韓商愛迪恩斯股份有限公司 以酞嗪酮衍生物治療病症的方法
EP4469051A4 (en) * 2022-01-25 2025-12-17 Idience Co Ltd Pharmaceutical composition with phthalazine derivative for simultaneous administration with an anticancer agent
WO2024025389A1 (ko) * 2022-07-29 2024-02-01 아이디언스 주식회사 프탈라지논 유도체의 중간체의 제조방법
CN117229260B (zh) * 2023-11-13 2024-02-27 中国药科大学 DNA聚合酶θ与聚ADP核糖聚合酶1双靶点抑制剂及其制备方法和医药用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228960B1 (hu) 2000-10-30 2013-07-29 Kudos Pharm Ltd Ftalazinon-származékok
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate
PL1633724T3 (pl) * 2003-03-12 2011-10-31 Kudos Pharm Ltd Pochodne ftalazynonu
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
GB0610680D0 (en) 2006-05-31 2006-07-12 Istituto Di Ricerche D Biolog Therapeutic compounds
JP5271897B2 (ja) 2006-05-31 2013-08-21 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ ポリ(ADP−リボース)ポリメラーゼ(PARP)の阻害剤としての、ピロロ[1,2−a]ピラジン−1(2H)−オン及びピロロ[1,2−d][1,2,4]トリアジン−1(2H)−オン誘導体
MX347085B (es) 2006-12-28 2017-04-06 Abbott Laboratories * Inhibidores de la poli (adp-ribosa) polimerasa.
CN101030723A (zh) 2007-04-04 2007-09-05 钟志华 电磁变相发动机
JP5758630B2 (ja) 2007-11-15 2015-08-05 エンメエッセディ・イタリア・エッセ・エッレ・エッレ Parp阻害剤としてのピリダジノン誘導体
AR070221A1 (es) 2008-01-23 2010-03-25 Astrazeneca Ab Derivados de ftalazinona inhibidores de polimerasas, composiciones farmaceuticas que los contienen y usos de los mismos para prevenir y/o tratar tumores cancerigenos,lesiones isquemicas y otras enfermedades asociadas.
GB0804755D0 (en) 2008-03-14 2008-04-16 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2012014221A1 (en) 2010-07-27 2012-02-02 Cadila Healthcare Limited Substituted 4-(4-fluoro-3-(piperazine-1- carbonyl)benzyl)phthalazin-1(2h)-one derivatives as poly (adp-ribose) polymerase- 1 inhibitors
CN102372706A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
CN102372716A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
CN102372698A (zh) 2010-08-10 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
EP2646428B1 (en) 2010-12-02 2016-06-01 Shanghai De Novo Pharmatech Co Ltd. Heterocyclic derivatives, preparation processes and medical uses thereof
CN102485721B (zh) 2010-12-03 2015-12-09 曹亚 取代的2,3-二氮杂萘酮化合物及其用途
CN103130723B (zh) * 2011-11-30 2015-01-14 成都地奥制药集团有限公司 一种多聚(adp-核糖)聚合酶抑制剂
KR101670126B1 (ko) * 2013-09-13 2016-10-27 일동제약(주) 신규 프탈라지논 유도체 및 그 제조방법

Similar Documents

Publication Publication Date Title
RU2016108038A (ru) Новые фталазиновые производные и способ их получения
USRE49556E1 (en) Compounds and compositions as protein kinase inhibitors
JP5736507B2 (ja) 含窒素複素環化合物またはその塩
JP2020503299A5 (enExample)
JP2016517878A5 (enExample)
JP2017512794A5 (enExample)
MX2020002060A (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos.
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
HRP20160118T1 (hr) HETEROCIKLIÄŚKI DERIVAT KAO INHIBITOR MIKROSOMSKIH SINTAZA PROSTAGLANDINA E (mPGEs)
RU2012126987A (ru) Спироиндолциклопропаниндолиноны в качестве модуляторов амрк
JP2017530185A5 (enExample)
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2
JP2017532360A5 (enExample)
EA032609B1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
JP2016523911A5 (enExample)
JP2019505541A5 (enExample)
JP2013532713A5 (enExample)
JP2019523266A5 (enExample)
NZ603525A (en) Pyrimidine based compound and uses thereof
RU2005108999A (ru) Азотсодержащие ароматические производные
JP2016503009A5 (enExample)
JP2016523935A5 (enExample)
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
RU2017120217A (ru) 2-амино-5,5-дифтор-6-(фторметил)-6-фенил-3,4,5,6-тетрагидпропиридины в качестве ингибиторов bace1
JP2012501312A5 (enExample)